Charles Parks Richardson

Education

Richardson received a B.S. degree in chemistry from Winston-Salem State University in Winston-Salem, North Carolina. He has an M.D. degree from Central America Health Sciences University School of Medicine. He holds an MBA from the University of South Carolina's Moore School of Business.

Career

Richardson co-founded the company Cleveland Heart. The company's medical technology focuses on total heart replacement and ventricular assist devices.

Richardson co-founded IntelliServices Inc. and was its CEO. The company offers remote electronic medical records. Its product CareLink allowed medical providers to wirelessly monitor implanted medical devices via the Internet. The company was sold and is now owned by Medtronic.

In 2004, Richardson founded TransWorld Med. He also serves as the company chairman.

In 2007, Richardson founded TransWorld Kidney Corporation.

Richardson is founder and chairman of Cleveland Heart, a partnership between Cleveland Clinic and TransWorld Med to develop mechanical cardiac circulatory assist devices and artificial hearts.

Inventions

Richardson created IntelliPhysician, a piece of software based on the same paperless principles as IntelliHeart, but handles a wider range of business-related processes, such as scheduling, accounts receivable, financial history, and billing. The software also processes insurance claim forms and gathers and stores patients’ clinical data, including procedure and diagnosis history, email, hospital rounds information, and referring physician information.

One of TransWorld Heart Corp.'s inventions is the Soul Mate. This product is an implantable device that can replace routine post-transplant heart biopsies. The Soul Mate was the first device to offer remote monitoring of congestive heat failure and allows physicians to track a patient's condition from home.

In 2007 Richardson developed the SideKick, a system for real-time monitoring of a kidney after a transplant.